Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Risk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).
Megna M, Orsini D, Assorgi C, Balato A, Balestri R, Bianchi L, Brianti P, Brunasso G, Buononato D, Burlando M, Cagni AE, Caldarola G, Cameli N, Campanati A, Campione E, Carrera CG, Carugno A, Chersi K, Costanzo A, Cusano F, D'Amico D, Dal Bello G, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Errichetti E, Esposito M, Fargnoli MC, Fiorella CS, Foti A, Gaiani FM, Gargiulo L, Gatti A, Gisondi P, Giunta A, Ibba L, Lasagni C, Loconsole F, Maione V, Malagoli P, Marzano AV, Maurelli M, Mercuri SR, Michelerio A, Michelucci A, Morrone P, Mortato E, Narcisi A, Offidani A, Paolino G, Parodi A, Pellacani G, Quaglino P, Richetta AG, Romano F, Sena P, Trevisan G, Uzzauto MT, Venturini M, Potestio L. Megna M, et al. Among authors: potestio l. Clin Exp Dermatol. 2024 Oct 7:llae400. doi: 10.1093/ced/llae400. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 39373543 No abstract available.
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
Megna M, Potestio L, Fabbrocini G, Cinelli E. Megna M, et al. Among authors: potestio l. Dermatol Ther. 2021 Sep;34(5):e15030. doi: 10.1111/dth.15030. Epub 2021 Jun 22. Dermatol Ther. 2021. PMID: 34137492 Free PMC article. No abstract available.
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".
Potestio L, Camela E, Fabbrocini G, Megna M. Potestio L, et al. J Cosmet Dermatol. 2021 Dec;20(12):4073-4075. doi: 10.1111/jocd.14550. Epub 2021 Oct 28. J Cosmet Dermatol. 2021. PMID: 34708906 Free PMC article. No abstract available.
Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.".
Potestio L, Camela E, Tajani A, Fabbrocini G, Megna M. Potestio L, et al. J Cosmet Dermatol. 2022 Mar;21(3):880-882. doi: 10.1111/jocd.14781. Epub 2022 Jan 27. J Cosmet Dermatol. 2022. PMID: 35037352 Free PMC article. No abstract available.
Teledermatology: A useful tool also after COVID-19 era?
Megna M, Camela E, Villani A, Tajani A, Fabbrocini G, Potestio L. Megna M, et al. Among authors: potestio l. J Cosmet Dermatol. 2022 Jun;21(6):2309-2310. doi: 10.1111/jocd.14938. Epub 2022 Apr 11. J Cosmet Dermatol. 2022. PMID: 35332660 Free PMC article. No abstract available.
183 results